GH-axis research catalogs usually have two kinds of compounds: GHRH analogs, which act at the GHRH receptor, and growth hormone secretagogues (GHS), which act at the ghrelin receptor. Below we compare the CJC-1295 + Ipamorelin blend with Tesamorelin.
Two Receptor Pathways
- GHRH receptor (GHRHR): targeted by CJC-1295 (no DAC), Sermorelin, and Tesamorelin.
- Ghrelin receptor (GHS-R1a): targeted by Ipamorelin and Hexarelin.
CJC-1295 + Ipamorelin
CJC-1295 without DAC (Mod GRF 1-29) is a 29-amino-acid GHRH analog. It carries four substitutions that make it more stable than native GHRH(1-29). Ipamorelin is a selective GHS-R1a pentapeptide. Combining the two lets researchers study both pathways in a single model, which is a common design for looking at receptor synergy in pulsatile GH signaling.
Tesamorelin
Tesamorelin is a full-length 44-amino-acid GHRH analog. A trans-3-hexenoyl group on the N-terminus protects it from DPP-4 cleavage. Because it acts on one well-characterized receptor, it is a useful single-pathway tool for GHRH receptor and downstream IGF-1 signaling research.
Comparison
| CJC-1295 + Ipamorelin | Tesamorelin | |
|---|---|---|
| Receptors | GHRHR + GHS-R1a | GHRHR |
| Length | 29 aa + 5 aa | 44 aa |
| Typical study design | Dual-pathway or synergy studies | Single-pathway GHRH studies |
The Tesamorelin + Ipamorelin blend combines both approaches in one vial. Browse the GH-Axis Research collection.
Other GH-Axis Research Tools
Sermorelin (GHRH 1-29) is a reference GHRHR agonist for comparison studies. Hexarelin is a more potent but less selective GHS-R1a agonist that also binds CD36. Downstream of the pituitary, IGF-1 LR3 is widely used as an IGF-1 receptor tool compound in cell culture. Together these let researchers probe the GH axis at several levels. Browse GH-Axis Research.
Pulsatility and Receptor Desensitization
Endogenous GH is released in pulses, and continuous receptor stimulation can lead to desensitization in research models. That is one reason study design matters so much in this category. Researchers compare continuous exposure with intermittent exposure, track receptor internalization, and measure how quickly signaling recovers after washout. Ghrelin-receptor agonists differ in how strongly they cause desensitization. Ipamorelin is often described as more selective than older secretagogues such as Hexarelin, which makes it a useful contrast compound in these experiments. Researchers often express washout recovery as the percentage of the initial response restored after a defined interval, which gives a simple number to compare across GHRH analogs and secretagogues.
Experimental Readouts for GH-Axis Peptides
In pituitary cell or ex-vivo models, researchers typically measure secreted GH by ELISA, collecting samples at several time points to capture release kinetics. GHRH analogs and GHS-R1a agonists signal through different pathways, Gs/cAMP and Gq/calcium respectively, so researchers often add calcium imaging or IP1 accumulation assays to separate the two.
Documenting Blend vs Single-Vial Arms
When you compare the CJC-1295 + Ipamorelin blend with separately reconstituted CJC-1295 (no DAC) and Ipamorelin, record the molar ratio in each arm. A blend has a fixed ratio, while separate stocks let you adjust it.
GH-Axis FAQ
What does "no DAC" mean? DAC (drug affinity complex) is a lysine-linked maleimide group that binds albumin. The no-DAC version, Mod GRF 1-29, does not have it.
Why is Tesamorelin 44 amino acids long? It is based on full-length GHRH(1-44), not the shorter 1-29 fragment.
Summary
- Two receptor pathways: GHRHR and GHS-R1a
- Use pathway-specific readouts
- The Tesamorelin + Ipamorelin blend combines both
- Related: storage and reconstitution guide
Research Use Only. All compounds referenced in this article are sold by Genetic Peptides USA strictly for in-vitro and laboratory research. They are not for human or animal consumption, are not drugs, foods, or cosmetics, and are not intended to diagnose, treat, cure, or prevent any disease. This article summarizes published scientific context for educational purposes and contains no dosing guidance.